Q3 2025 Schrodinger Inc Earnings Call Transcript
Key Points
- Schrodinger Inc (SDGR) reported a 54% increase in total revenue for Q3 2025 compared to Q3 2024, reaching $54 million.
- Software revenue grew by 28% year-over-year, totaling $40.9 million, slightly exceeding expectations.
- The company has successfully reduced R&D expenses by 16% and sales and marketing expenses by 8% compared to Q3 2024.
- Schrodinger Inc (SDGR) has generated approximately $600 million in cash from collaborations and licensing activities since 2020.
- The company remains well-capitalized with $401 million in cash and equivalents as of September 30, 2025.
- Schrodinger Inc (SDGR) lowered its software revenue growth guidance for 2025 from 10-15% to 8-13% due to delays in pharma scale-up opportunities.
- The biotech sector's challenges have been greater than expected, impacting new customer acquisition and contributing to the revised guidance.
- Net loss for Q3 2025 was $33 million, although this is an improvement from a $38 million loss in Q3 2024.
- The company has decided not to advance internal discovery programs into the clinic independently, which may limit potential future revenue streams.
- There is uncertainty regarding the timing of closing scale-up opportunities with pharmaceutical customers, affecting revenue visibility.
Thank you for standing by. Welcome to Shortinger's conference call to review 3rd quarter 2025 financial results. My name is Rob and I'll be your operator for today's call. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question-and-answer session. If you'd like to ask a question during this time, simply press start, then the number one on your telephone keypad. Please be advised that this call is being recorded at the company's request. Now I would like to introduce your host for today's conference, Ms. Jaron Madden, chief corporate affairs officer and head of investor relations. Please go ahead.
Thank you and good afternoon, everyone. Welcome to today's call, during which we will provide an update on the company and review our third quarter 2025 financial results. Earlier today, we issued a press release summarizing our financial results and progress across the company, which is available on our website
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
